Report Detail
Global Meningococcal Infections Vaccine Market 2019 by Manufacturers, Countries, Type and Application, Forecast to 2024
- RnM3779631 |
- 25 September, 2019 |
- Global |
- 105 Pages |
- GIR (Global Info Research) |
- Other
Meningococcal vaccine refers to any of the vaccines used to prevent infection by Neisseria meningitidis.Different versions are effective against some or all of the following types of meningococcus: A, C, W-135,and Y.The vaccines are between 85 and 100% effective for at least two years.They result in a decrease in meningitis and sepsis among populations where they are widely used.They are given either by injection into a muscle or just under the skin.
Scope of the Report:
The global Meningococcal Infections Vaccine market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Meningococcal Infections Vaccine.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Meningococcal Infections Vaccine market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Meningococcal Infections Vaccine market by product type and applications/end industries.
Market Segment by Companies, this report covers
Creative Biolabs(USA)
SERUM INSTITUTE OF INDIA PVT.LTD.(India)
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Quadrivalent (Serogroups A, C, W-135, and Y)
Bivalent (Serogroups C and Y)
Serogroup A
Serogroup B
Serogroup X
Market Segment by Applications, can be divided into
Hospital
Clinic
Table of Contents
1 Meningococcal Infections Vaccine Market Overview
- 1.1 Product Overview and Scope of Meningococcal Infections Vaccine
- 1.2 Classification of Meningococcal Infections Vaccine by Types
- 1.2.1 Global Meningococcal Infections Vaccine Revenue Comparison by Types (2019-2024)
- 1.2.2 Global Meningococcal Infections Vaccine Revenue Market Share by Types in 2018
- 1.2.3 Quadrivalent (Serogroups A, C, W-135, and Y)
- 1.2.4 Bivalent (Serogroups C and Y)
- 1.2.5 Serogroup A
- 1.2.6 Serogroup B
- 1.2.7 Serogroup X
- 1.3 Global Meningococcal Infections Vaccine Market by Application
- 1.3.1 Global Meningococcal Infections Vaccine Market Size and Market Share Comparison by Applications (2014-2024)
- 1.3.2 Hospital
- 1.3.3 Clinic
- 1.4 Global Meningococcal Infections Vaccine Market by Regions
- 1.4.1 Global Meningococcal Infections Vaccine Market Size (Million USD) Comparison by Regions (2014-2024)
- 1.4.1 North America (USA, Canada and Mexico) Meningococcal Infections Vaccine Status and Prospect (2014-2024)
- 1.4.2 Europe (Germany, France, UK, Russia and Italy) Meningococcal Infections Vaccine Status and Prospect (2014-2024)
- 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Meningococcal Infections Vaccine Status and Prospect (2014-2024)
- 1.4.4 South America (Brazil, Argentina, Colombia) Meningococcal Infections Vaccine Status and Prospect (2014-2024)
- 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Meningococcal Infections Vaccine Status and Prospect (2014-2024)
- 1.5 Global Market Size of Meningococcal Infections Vaccine (2014-2024)
2 Manufacturers Profiles
- 2.1 Creative Biolabs(USA)
- 2.1.1 Business Overview
- 2.1.2 Meningococcal Infections Vaccine Type and Applications
- 2.1.2.1 Product A
- 2.1.2.2 Product B
- 2.1.3 Creative Biolabs(USA) Meningococcal Infections Vaccine Revenue, Gross Margin and Market Share (2017-2018)
- 2.2 SERUM INSTITUTE OF INDIA PVT.LTD.(India)
- 2.2.1 Business Overview
- 2.2.2 Meningococcal Infections Vaccine Type and Applications
- 2.2.2.1 Product A
- 2.2.2.2 Product B
- 2.2.3 SERUM INSTITUTE OF INDIA PVT.LTD.(India) Meningococcal Infections Vaccine Revenue, Gross Margin and Market Share (2017-2018)
3 Global Meningococcal Infections Vaccine Market Competition, by Players
- 3.1 Global Meningococcal Infections Vaccine Revenue and Share by Players (2014-2019)
- 3.2 Market Concentration Rate
- 3.2.1 Top 5 Meningococcal Infections Vaccine Players Market Share
- 3.2.2 Top 10 Meningococcal Infections Vaccine Players Market Share
- 3.3 Market Competition Trend
4 Global Meningococcal Infections Vaccine Market Size by Regions
- 4.1 Global Meningococcal Infections Vaccine Revenue and Market Share by Regions
- 4.2 North America Meningococcal Infections Vaccine Revenue and Growth Rate (2014-2019)
- 4.3 Europe Meningococcal Infections Vaccine Revenue and Growth Rate (2014-2019)
- 4.4 Asia-Pacific Meningococcal Infections Vaccine Revenue and Growth Rate (2014-2019)
- 4.5 South America Meningococcal Infections Vaccine Revenue and Growth Rate (2014-2019)
- 4.6 Middle East and Africa Meningococcal Infections Vaccine Revenue and Growth Rate (2014-2019)
5 North America Meningococcal Infections Vaccine Revenue by Countries
- 5.1 North America Meningococcal Infections Vaccine Revenue by Countries (2014-2019)
- 5.2 USA Meningococcal Infections Vaccine Revenue and Growth Rate (2014-2019)
- 5.3 Canada Meningococcal Infections Vaccine Revenue and Growth Rate (2014-2019)
- 5.4 Mexico Meningococcal Infections Vaccine Revenue and Growth Rate (2014-2019)
6 Europe Meningococcal Infections Vaccine Revenue by Countries
- 6.1 Europe Meningococcal Infections Vaccine Revenue by Countries (2014-2019)
- 6.2 Germany Meningococcal Infections Vaccine Revenue and Growth Rate (2014-2019)
- 6.3 UK Meningococcal Infections Vaccine Revenue and Growth Rate (2014-2019)
- 6.4 France Meningococcal Infections Vaccine Revenue and Growth Rate (2014-2019)
- 6.5 Russia Meningococcal Infections Vaccine Revenue and Growth Rate (2014-2019)
- 6.6 Italy Meningococcal Infections Vaccine Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Meningococcal Infections Vaccine Revenue by Countries
- 7.1 Asia-Pacific Meningococcal Infections Vaccine Revenue by Countries (2014-2019)
- 7.2 China Meningococcal Infections Vaccine Revenue and Growth Rate (2014-2019)
- 7.3 Japan Meningococcal Infections Vaccine Revenue and Growth Rate (2014-2019)
- 7.4 Korea Meningococcal Infections Vaccine Revenue and Growth Rate (2014-2019)
- 7.5 India Meningococcal Infections Vaccine Revenue and Growth Rate (2014-2019)
- 7.6 Southeast Asia Meningococcal Infections Vaccine Revenue and Growth Rate (2014-2019)
8 South America Meningococcal Infections Vaccine Revenue by Countries
- 8.1 South America Meningococcal Infections Vaccine Revenue by Countries (2014-2019)
- 8.2 Brazil Meningococcal Infections Vaccine Revenue and Growth Rate (2014-2019)
- 8.3 Argentina Meningococcal Infections Vaccine Revenue and Growth Rate (2014-2019)
- 8.4 Colombia Meningococcal Infections Vaccine Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Meningococcal Infections Vaccine by Countries
- 9.1 Middle East and Africa Meningococcal Infections Vaccine Revenue by Countries (2014-2019)
- 9.2 Saudi Arabia Meningococcal Infections Vaccine Revenue and Growth Rate (2014-2019)
- 9.3 UAE Meningococcal Infections Vaccine Revenue and Growth Rate (2014-2019)
- 9.4 Egypt Meningococcal Infections Vaccine Revenue and Growth Rate (2014-2019)
- 9.5 Nigeria Meningococcal Infections Vaccine Revenue and Growth Rate (2014-2019)
- 9.6 South Africa Meningococcal Infections Vaccine Revenue and Growth Rate (2014-2019)
10 Global Meningococcal Infections Vaccine Market Segment by Type
- 10.1 Global Meningococcal Infections Vaccine Revenue and Market Share by Type (2014-2019)
- 10.2 Global Meningococcal Infections Vaccine Market Forecast by Type (2019-2024)
- 10.3 Quadrivalent (Serogroups A, C, W-135, and Y) Revenue Growth Rate (2014-2024)
- 10.4 Bivalent (Serogroups C and Y) Revenue Growth Rate (2014-2024)
- 10.5 Serogroup A Revenue Growth Rate (2014-2024)
- 10.6 Serogroup B Revenue Growth Rate (2014-2024)
- 10.7 Serogroup X Revenue Growth Rate (2014-2024)
11 Global Meningococcal Infections Vaccine Market Segment by Application
- 11.1 Global Meningococcal Infections Vaccine Revenue Market Share by Application (2014-2019)
- 11.2 Meningococcal Infections Vaccine Market Forecast by Application (2019-2024)
- 11.3 Hospital Revenue Growth (2014-2019)
- 11.4 Clinic Revenue Growth (2014-2019)
12 Global Meningococcal Infections Vaccine Market Size Forecast (2019-2024)
- 12.1 Global Meningococcal Infections Vaccine Market Size Forecast (2019-2024)
- 12.2 Global Meningococcal Infections Vaccine Market Forecast by Regions (2019-2024)
- 12.3 North America Meningococcal Infections Vaccine Revenue Market Forecast (2019-2024)
- 12.4 Europe Meningococcal Infections Vaccine Revenue Market Forecast (2019-2024)
- 12.5 Asia-Pacific Meningococcal Infections Vaccine Revenue Market Forecast (2019-2024)
- 12.6 South America Meningococcal Infections Vaccine Revenue Market Forecast (2019-2024)
- 12.7 Middle East and Africa Meningococcal Infections Vaccine Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
Summary:
Get latest Market Research Reports on Meningococcal Infections Vaccine. Industry analysis & Market Report on Meningococcal Infections Vaccine is a syndicated market report, published as Global Meningococcal Infections Vaccine Market 2019 by Manufacturers, Countries, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Meningococcal Infections Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
